Stada Saga Set To End As Board Backs Bain And Cinven Bid
The equity firms finally look like getting their hands on the German generics group as Stada urges shareholders to back the €4.1bn deal and only 63% need to support it.
The equity firms finally look like getting their hands on the German generics group as Stada urges shareholders to back the €4.1bn deal and only 63% need to support it.